TRANSPARENCY: CoST Uganda Commissions 2nd Infrastructure Transparency Index
Shift Media News 
By Our Reporter
GULU, UGANDA-SHIFTMEDIA- Just a day after the National Drug Authority (NDA) stopped Gulu University from manufacturing the Covid 19 herbal drug Covilyce, President Museveni has agreed to release shs 3b requested by inventor Dr. Lamwaka Alice.
According to the latest information, the funds will be used for covilyce clinical trials and Mass production. The clinical trials will be done from GULU regional referral Hospital.
On Wednesday the National Drug Authority ordered Gulu University to cease production of Covilyce-1, a herbal medicine that the varsity developed to treat Covid-19, saying it has not yet been approved.
The statutory regulator’s directive comes a few days after the university scientists led by Dr. Alice Veronica Lamwaka announced that 100 Covid-19 patients who used Covilyce-1 had recovered.
Dr. Lamwaka reportedly made an appeal for Shs200m support to increase production due to soaring demand for the herbal medicine several of whose users testify that it works to treat the pandemic.
Dr. Lamwaka, who said she met President Museveni on Monday, revealed that they are facing financial challenges which are affecting their production to cover the whole country.
“We need about Shs200 million to carry out mass production. When the demand became high, we got some little money that we used for buying containers because some orders are coming from other districts,” she said.
Highly-placed sources intimated to this newspaper that the President, for unstated reason, asked Dr. Lamwaka to stop media engagement.
Following a week of a media blitz, security abruptly restrained Prof Ogwang from granting more interviews.
About Covilyce-1
A group of more than 10 scientists at Gulu University have formulated Covilyce-1, an assortment of four different herbal medicines they claim cure Covid-19.
The drug comes in four formulas; Linctus (made from four plants), Covilyce-1 Powder (a combination of eight plants), Covilyce-1 Suppository (made from 3 plants) and Covilyce-1 Nasal drops (made from 6 herbs).
The researchers started using the concoctions of eight different herbs in January 2021, after doing phytochemical analysis on the herbs, to find out what active ingredients are present in them and what they could cure.
Covid-19 patients with mild symptoms enrolled on the nasal drops (in the mouth, ears, and nose) recovered between 12-72 hours while those with nasal congestion and chest pain use the Linctus.
Patients with co-morbidities like hypertension, asthma, ulcers, and diabetes, use a combination of Covilyce-1 powder, Linctus, and Nasal drops that clears the infection in approximately 12 hours.
